Compare Samsara Inc (IOT) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Samsara Inc vs Stryker Corporation — how do they compare? Samsara Inc trades at $41.55 (market cap $24.14B), while Stryker Corporation trades at $277.33 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 4.4× Samsara Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Samsara Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Samsara Inc for 19 Days and Stryker Corporation for 21 Days on average.
| IOT | SYK | |
|---|---|---|
Market Cap | $24.14B | $106.24B |
Volume | 5,372,580 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $45.22 | $388.35 |
52-Week Low | $24.25 | $269.75 |
Typical Hold Time | 19 Days | 21 Days |
Enterprise Value | $23.38B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Samsara (IOT) trades at $41.55, up 2.57% today, with a bullish technical signal and strong analyst support. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $0.20 exceeding the $0.16 forecast. Revenue growth is robust, projected to rise from $1.25B in 2025 to $1.8B in 2026, while the company transitions to profitability with a net margin of 4.9% in 2026. Recent partnerships and product launches, like the Laval Rocket sponsorship and Samsara MCP, highlight ongoing business expansion.
The outlook is positive, driven by 30% annual recurring revenue growth and large-customer adoption, though high valuation multiples (P/E 274.8, P/S 13.01) pose a risk if growth slows. Analyst consensus is strongly bullish with a $51.15 price target, but investors should monitor cash flow pressures and competitive threats in the connected operations software space.
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Samsara Inc
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
